Stock 688075 ASSURE TECH (HANGZHOU) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Assure Tech (Hangzhou) Co., Ltd.

Equities

688075

CNE100004ZC0

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
36.08 CNY +5.81% Intraday chart for Assure Tech (Hangzhou) Co., Ltd. +9.27% -10.43%
Feb. 28 Assure Tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Assure Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 8,783 7,652 5,119
Enterprise Value (EV) 1 6,740 4,155 3,049
P/E ratio 9.17 x 2.51 x 36.3 x
Yield 2.71% 5.93% -
Capitalization / Revenue 5.53 x 1.24 x 10.2 x
EV / Revenue 4.24 x 0.67 x 6.06 x
EV / EBITDA 7.62 x 1.29 x 36.2 x
EV / FCF 33.5 x 11.1 x -2.73 x
FCF Yield 2.99% 9.01% -36.7%
Price to Book 3.37 x 1.41 x 1 x
Nbr of stocks (in thousands) 127,083 127,083 127,083
Reference price 2 69.11 60.21 40.28
Announcement Date 4/27/22 4/28/23 4/29/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 163.7 209.8 1,200 1,589 6,166 503.4
EBITDA 1 42.91 62.41 794.6 884.9 3,219 84.27
EBIT 1 39.73 58.81 790.4 874.3 3,184 27.77
Operating Margin 24.26% 28.03% 65.88% 55.01% 51.63% 5.52%
Earnings before Tax (EBT) 1 41.07 62.29 761.4 864.6 3,520 143.8
Net income 1 33.37 54.47 649 738.5 3,045 141.6
Net margin 20.38% 25.96% 54.09% 46.47% 49.38% 28.12%
EPS 2 0.6371 0.6033 6.810 7.539 23.96 1.110
Free Cash Flow 1 -27.31 -10.3 393.3 201.3 374.2 -1,118
FCF margin -16.68% -4.91% 32.78% 12.66% 6.07% -222.02%
FCF Conversion (EBITDA) - - 49.49% 22.75% 11.62% -
FCF Conversion (Net income) - - 60.6% 27.25% 12.29% -
Dividend per Share - - - 1.873 3.571 -
Announcement Date 6/2/20 6/2/20 4/27/22 4/27/22 4/28/23 4/29/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 48.5 65.2 613 2,043 3,498 2,070
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -27.3 -10.3 393 201 374 -1,118
ROE (net income / shareholders' equity) 40.2% 41.1% 133% 43.2% 75.9% 2.68%
ROA (Net income/ Total Assets) 14.3% 18.1% 74.9% 24.9% 38.9% 0.27%
Assets 1 233 300.4 866.4 2,961 7,821 51,927
Book Value Per Share 2 1.960 1.700 8.520 20.50 42.70 40.20
Cash Flow per Share 2 1.010 0.6800 6.440 16.10 16.80 2.650
Capex 1 18.4 9.26 40.1 200 627 337
Capex / Sales 11.26% 4.41% 3.34% 12.56% 10.16% 66.9%
Announcement Date 6/2/20 6/2/20 4/27/22 4/27/22 4/28/23 4/29/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Diagnostic & Testing Substances

1st Jan change Capi.
ASSURE TECH (HANGZHOU) CO., LTD. Stock Assure Tech (Hangzhou) Co., Ltd.
-10.43% 599M
BIOMÉRIEUX Stock bioMérieux
-0.60% 12.95B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.84B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+1.82% 5.5B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.61B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+7.32% 4.61B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-47.68% 3.4B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.66B
VITROLIFE AB Stock Vitrolife AB
-14.59% 2.08B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+2.25% 1.79B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 688075 Stock
  4. Financials Assure Tech (Hangzhou) Co., Ltd.